The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: The peptide marker for the prognosis of cancer

Kamaldeep Gill; Bidhu Kalyan Mohanti; Abhay Kumar Singh; Biswajit Mishra; Sharmistha Dey

doi:10.3233/CBM-2012-0238

The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: The peptide marker for the prognosis of cancer

Kamaldeep Gill, Bidhu Kalyan Mohanti, Abhay Kumar Singh, Biswajit Mishra, Sharmistha Dey

Department of Radiation Oncology

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

The over expression of LL37, an antimicrobial peptide belonging~to the cathelicidin family has implication in the progression of human malignancy but the exact role is still not clear. This study aims to elucidate the correlation of LL37 with Head and Neck Squamous Cell Carcinoma (HNSCC) and the consequences of radiotherapy on it. The LL37 levels were quantified in serum samples of control and HNSCC patients at pre-RT, during-RT and post-RT using a real time Surface Plasmon Resonance technology and ELISA. The LL37 of 50 HNSCC patients was significantly (p< 0.0001) threefold higher than the 25 controls and declined with respect to radiation therapy (p< 0.0001) supporting its candidature as a prognostic marker in HNSCC.

Original language	English
Pages (from-to)	125-134
Number of pages	10
Journal	Cancer Biomarkers
Volume	10
Issue number	3-4
DOIs	https://doi.org/10.3233/CBM-2012-0238
State	Published - 2011

Keywords

HNSCC
LL37
prognostic marker
radiation therapy

Access to Document

10.3233/CBM-2012-0238

Cite this

@article{60b55b04b05c40e781e819e90460b6d5,

title = "The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: The peptide marker for the prognosis of cancer",

abstract = "The over expression of LL37, an antimicrobial peptide belonging~to the cathelicidin family has implication in the progression of human malignancy but the exact role is still not clear. This study aims to elucidate the correlation of LL37 with Head and Neck Squamous Cell Carcinoma (HNSCC) and the consequences of radiotherapy on it. The LL37 levels were quantified in serum samples of control and HNSCC patients at pre-RT, during-RT and post-RT using a real time Surface Plasmon Resonance technology and ELISA. The LL37 of 50 HNSCC patients was significantly (p< 0.0001) threefold higher than the 25 controls and declined with respect to radiation therapy (p< 0.0001) supporting its candidature as a prognostic marker in HNSCC.",

keywords = "HNSCC, LL37, prognostic marker, radiation therapy",

author = "Kamaldeep Gill and Mohanti, {Bidhu Kalyan} and Singh, {Abhay Kumar} and Biswajit Mishra and Sharmistha Dey",

year = "2011",

doi = "10.3233/CBM-2012-0238",

language = "English",

volume = "10",

pages = "125--134",

journal = "Cancer Biomarkers",

issn = "1574-0153",

number = "3-4",

}

TY - JOUR

T1 - The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma

T2 - The peptide marker for the prognosis of cancer

AU - Gill, Kamaldeep

AU - Mohanti, Bidhu Kalyan

AU - Singh, Abhay Kumar

AU - Mishra, Biswajit

AU - Dey, Sharmistha

PY - 2011

Y1 - 2011

N2 - The over expression of LL37, an antimicrobial peptide belonging~to the cathelicidin family has implication in the progression of human malignancy but the exact role is still not clear. This study aims to elucidate the correlation of LL37 with Head and Neck Squamous Cell Carcinoma (HNSCC) and the consequences of radiotherapy on it. The LL37 levels were quantified in serum samples of control and HNSCC patients at pre-RT, during-RT and post-RT using a real time Surface Plasmon Resonance technology and ELISA. The LL37 of 50 HNSCC patients was significantly (p< 0.0001) threefold higher than the 25 controls and declined with respect to radiation therapy (p< 0.0001) supporting its candidature as a prognostic marker in HNSCC.

AB - The over expression of LL37, an antimicrobial peptide belonging~to the cathelicidin family has implication in the progression of human malignancy but the exact role is still not clear. This study aims to elucidate the correlation of LL37 with Head and Neck Squamous Cell Carcinoma (HNSCC) and the consequences of radiotherapy on it. The LL37 levels were quantified in serum samples of control and HNSCC patients at pre-RT, during-RT and post-RT using a real time Surface Plasmon Resonance technology and ELISA. The LL37 of 50 HNSCC patients was significantly (p< 0.0001) threefold higher than the 25 controls and declined with respect to radiation therapy (p< 0.0001) supporting its candidature as a prognostic marker in HNSCC.

KW - HNSCC

KW - LL37

KW - prognostic marker

KW - radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84862855593&partnerID=8YFLogxK

U2 - 10.3233/CBM-2012-0238

DO - 10.3233/CBM-2012-0238

M3 - Article

C2 - 22674298

AN - SCOPUS:84862855593

SN - 1574-0153

VL - 10

SP - 125

EP - 134

JO - Cancer Biomarkers

JF - Cancer Biomarkers

IS - 3-4

ER -

The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: The peptide marker for the prognosis of cancer

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this